Biopharmaceutical
Cardiovascular
Therapies
Usa
Development
Unitedstates
M&A Advisory
Lazard
Full Credential Description
Myogen. United States. Announced Date 16/09/2005. Closed Date 16/09/2005. Deal value: $125m. Common stock. Industry: Myogen was a biopharmaceutical company focused on developing therapies for cardiovascular diseases.